Clinical Trial

Beta3-adrenergic Receptors and Cardiovascular Function in Aging Women

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
To determine if vascular beta3 adrenergic receptors are present and functional in aging women and can be targeted to attenuate sympathetic vasoconstriction and enhance vascular function in aging women.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-23.
Trial Details
NCT Number NCT07674680
Lead Sponsor University of Missouri-Columbia
Conditions Women, Aging, Menopause
Enrollment 60 participants
Start Date 2026-07
Primary Completion 2028-05 (estimated)
Study Completion 2029-05 (estimated)
Updated on ClinicalTrials.gov 2026-07-28